Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/APLI stock hub

TSX/APLI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/APLIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/APLI

In the news

Latest news · TSX/APLI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/APLI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

CAD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	7
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD 14.2M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA03783R1073
Last refreshed	2026-05-10
Market cap	CAD 2M
Price	CAD 0.02
Price currency	CAD
Rev Per Employee	29,472.86x
Sector	Healthcare
Sic	2834
Symbol	tsx/APLI
Website	https://appilitherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-149.26%
EV Earnings	-4.8x
EV/Sales	68.99x
P/B ratio	-0.12x
P/S ratio	9.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	CAD 206,310
Gross Profit Growth	65.38%
Gross Profit Growth Q	6.11%
Net Income	CAD -3M
Net Income Growth Years	3%
Pretax Margin	-1,391.89%
Profit Per Employee	CAD -423,375
ROA	-292
Roa5y	-153.1
ROCE	39.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.02%
Cagr3y	-24.6%
Cagr5y	-58.51%
EPS Growth Years	3
Revenue Growth	65.38x
Revenue Growth Q	6.11x
Revenue Growth Quarters	2x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.16
Assets	CAD 547,913
Cash	CAD 212,754
Current Assets	CAD 535,603
Current Liabilities	CAD 16.2M
Debt	CAD 12.5M
Equity	CAD -16.4M
Interest Coverage	-4.69
Liabilities	CAD 16.9M
Long Term Assets	CAD 12,310
Long Term Liabilities	CAD 736,800
Net Cash	CAD -12.2M
Net Cash By Market Cap	CAD -617
Tangible Book Value	CAD -16.4M
Tangible Book Value Per Share	CAD -0.13
WACC	7.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.03
Net Working Capital	CAD -4.1M
Quick ratio	0.02
Working Capital	CAD -15.7M
Working Capital Turnover	CAD -0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50%
200-day SMA	0.02
3Y total return	-57.14%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.77%
All Time High	1.89
All Time High Change	-99.21%
All Time High Date	2020-05-19
All Time Low	0.01
All Time Low Change	50%
All Time Low Date	2025-06-17
ATR	0
Beta	-0.3
Beta1y	-0.82
Beta2y	0.9
Ch YTD	-40
High	0.02
High52	0.04
High52 Date	2025-10-02
High52ch	-62.5%
Low	0.02
Low52	0.01
Low52 Date	2025-09-22
Low52ch	50%
Ma50ch	-24.62%
Price vs 200-day SMA	-30.56%
RSI	45.15
RSI Monthly	35.62
RSI Weekly	42.53
Sharpe ratio	0.9x
Sortino ratio	1.72
Total Return	-4.39%
Tr YTD	-40
Tr1m	-25%
Tr3m	-40%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -6.2M
Operating margin	-2,990.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,932,509%
Net Borrowing	-104,810
Shares Insiders	0.06%
Shares Out	132,366,120
Shares Qo Q	5.85%
Shares Yo Y	4.39%
Short Float	0.01%
Short Shares	0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	59,236.65x
Bv Per Share	-0.13
Ch1m	-25
Ch1y	-50
Ch3m	-40
Ch3y	-57.14
Ch5y	-98.77
Ch6m	-40
Change	0%
Change From Open	0
Close	0.02
Days Gap	0
Depreciation Amortization	10,068
Earnings Date	2026-06-23
EBIT	CAD -6.2M
EBITDA	CAD -6.2M
EPS	CAD -0.02
F Score	3
Financing CF	-31,407
Fiscal Year End	March
Founded	2,015
Income Tax	CAD 92,016
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Ma150	0.02
Ma150ch	-29.25%
Ma20	0.02
Ma20ch	-16.67%
Net CF	26,588
Next Earnings Date	2026-06-23
Open	0.02
Ppne	12,310
Price Date	2026-05-07
Relative Volume	0.84x
Revenue	206,310x
SBC By Revenue	24.94x
Share Based Comp	51,458
Tax By Revenue	44.6x
Tr6m	-40%
Volume	0
Z Score	-262.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/APLI pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/APLI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/APLI?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

+0.0%

Float sold short by bearish positioning

Y/Y dilution

+4.4%

Negative means the company is buying back shares.

Technical

TSX/APLI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.1

Neutral momentum band

Price vs 200-day MA

-30.6%

50/200-day relationship not available

Beta (5Y)

-0.30

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/APLI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/APLI stock rating?

tsx/APLI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/APLI analysis?

The full report lives at /stocks/tsx/APLI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/APLI?

The latest report frames tsx/APLI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/APLI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.